Tyra Biosciences, Inc. (TYRA) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
TYRA currently has 61.7M outstanding shares. with significant dilution risk as 56.5M authorized shares could dilute existing holders by 91.4%. The company has significantly diluted shareholders by 29.31% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 13, 2026 |
10-Q filing | 61.7M shares outstanding |
62M | 56M |
| Aug 14, 2025 |
10-Q filing | 53.3M shares outstanding |
53M | 56M |
| May 08, 2025 |
10-Q filing | 53.2M shares outstanding |
53M | 56M |
| May 08, 2025 |
S-3 filing: The company is offering common stock, preferred stock, and debt securities for a total aggregate amount of $500,000,000. |
53M | 56M |
| Mar 27, 2025 |
10-K filing | 57.2M shares outstanding |
57M | 41M |
| Nov 07, 2024 |
10-Q filing | 50.6M shares outstanding |
51M | 41M |
| Aug 07, 2024 |
10-Q filing | 52.8M shares outstanding |
53M | 41M |
| May 09, 2024 |
10-Q filing | 52.2M shares outstanding |
52M | 41M |
| Mar 19, 2024 |
S-3 filing: This S-3 filing relates to the proposed resale of up to 15,373,253 shares of common stock by selling securityholders, including shares issuable upon exercise of pre-funded warrants, with the company not receiving any proceeds from the sale. |
43M | 41M |
| Mar 19, 2024 |
10-K filing | 52.5M shares outstanding |
53M | 41M |
| Nov 07, 2023 |
10-Q filing | 42.9M shares outstanding |
43M | 26M |
| Aug 10, 2023 |
10-Q filing | 42.6M shares outstanding |
43M | 26M |
| May 04, 2023 |
10-Q filing | 42.4M shares outstanding |
42M | 26M |
| Mar 22, 2023 |
10-K filing | 41.9M shares outstanding |
42M | 26M |
| Nov 03, 2022 |
10-Q filing | 42.0M shares outstanding |
42M | 26M |
| Oct 03, 2022 |
S-3 filing: The company is filing an S-3 to offer and sell up to $400,000,000 in the aggregate of common stock, preferred stock and debt securities from time to time in one or more offerings. |
43M | 26M |
| Aug 04, 2022 |
10-Q filing | 41.8M shares outstanding |
42M | 9M |
| May 05, 2022 |
10-Q filing | 41.8M shares outstanding |
42M | 9M |
| Mar 03, 2022 |
10-K filing | 41.6M shares outstanding |
42M | 9M |
| Nov 03, 2021 |
10-Q filing | 41.3M shares outstanding |
41M | 9M |
| Sep 14, 2021 |
S-1/A filing: Tyra Biosciences, Inc. is offering 9,000,000 shares of its common stock in an initial public offering, with an estimated price range of $14.00 to $16.00 per share. |
39M | 9M |
| Sep 09, 2021 |
S-1/A filing: Tyra Biosciences, Inc. is offering 6,700,000 shares of its common stock in its initial public offering. |
37M | 7.7M |
| Aug 20, 2021 |
S-1 filing: This is an S-1 filing for an initial public offering of common stock for Tyra Biosciences, Inc. |
12M | 0 |